As of Nov 2, 2026: Laurence N. Charney (Director, TGTX) reported 1 sale for $275K in the last 12 months (Form 4). TGTX's Quality Score is 21. Scores as of 3:51 PM ET, 15 minutes behind.

Laurence N. Charney

Director of TG Therapeutics

1 stock trade in the last 12 months, shares they bought or sold themselves (not grants or options).

Bought$012 months Sold$275K12 months Last filedSep 14a sale

From SEC Form 4s · Insiders have 2 business days to file a trade

Every trade Laurence N. Charney reported

Newest first, as filed

Stock	Trade	Amount	Trade	Shares	Traded Filed
TGTXTG Therapeutics	Sell	$275Kat $54.96	Sell$275Kat $54.96	5,000 at $54.96	Sep 10filed Sep 14SEC filing

Their filings on the SEC's siteEvery Form 4 they filed, as filed, on EDGAR.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

See the tradeSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Laurence N. Charney's companies

Where they file, with the stock's Quality Score

Company	Title, as filed	Trades	Quality Score
TGTXTG TherapeuticsDirector	Directorfiled Sep 14	1	21

Alerts for Laurence N. Charney

One alert for each Form 4 they file.

Set an alert

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Use this page

Kept by Andrew Gomes, Breakaway's founder, from the SEC's Form 4 filings. Updated Sep 14, 2026.

Free to reuse with a link to this page.

How to cite

Breakaway, Laurence N. Charney: Director at TG Therapeutics (TGTX), Sep 14, 2026, getbreakaway.com/insiders/laurence-n-charney

Journalists: email support@getbreakaway.com for the data behind this page.

Others who file at TG Therapeutics

Insider trades by person